Scarce data on new glucose-lowering agents, with high risk for bias toward negative outcomes
Read More »The American Diabetes Association, June 22-26
The American Diabetes Association’s 78th Scientific Sessions The annual meeting of the American Diabetes Association (ADA) was held from June 22 to 26 in Orlando, Florida, and attracted approximately 14,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the …
Read More »Genetic Risk, Lifestyle Predict CVD, Diabetes Independently
No interactions seen for any outcome; log-additive effect on risk of developing cardiovascular disease
Read More »FDA Approves Continuous Glucose Monitoring System
Eversense CGM, which has fully implantable sensor to detect glucose, approved for adults with diabetes
Read More »Intervention Programs Prevent Diabetes Distress in Teens
Findings based on one-year follow-up in teens with type 1 diabetes participating in the STePS study
Read More »Few Hemodialysis Patients on Medicare Enroll in Hospice
Patterns of use, timing of hospice similar among patients with diverse spending trajectories
Read More »Insulin Glargine 300 Safe, Effective in Seniors With T2DM
Significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100
Read More »ADA: Closed-Loop Insulin Improves Glycemic Control
Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM
Read More »ADA: T1D, T2D, GDM Before 26 Weeks Tied to Higher ASD Risk
Increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes
Read More »Aspirin Use Doesn’t Cut Cancer Incidence in Older T2DM Patients
In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years
Read More »